We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Elevar Therapeutics today announced that the Board of Directors has appointed Kate McKinley, who has served as the Company's Chief Commercial Officer (CCO) since 2019, to Chief Executive Officer (CEO) of Elevar, effective immediately.